News

CVS Health's Caremark to Lead CalPERS' PBM Vision: What's at Stake?
CVS wins a major CalPERS deal as Caremark replaces OptumRx, backed by $250M in performance guarantees and drug cost controls.
India Today on MSN2d
US employers to cut health benefits amid soaring weight-loss drug costs: Survey
Over half of large US employers plan to cut health benefits in 2026 as rising costs of weight-loss drugs like Wegovy drive up spending, Mercer's latest survey reveals.
WGAU Radio2d
FDA reauthorizes Juul e-cigarettes, refills
The FDA announced on Thursday that Juul can keep its products on the market, after the company submitted studies that claim ...
Honolulu Star-Advertiser4d
Weight-loss drug costs drive employers to trim health benefits
NEW YORK >> More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from ...
KSL4d
Many employers plan to pare health benefits as weight-loss spending soars
More than half of large employers plan to scale back health care benefits next year as rising costs from weight-loss and specialty drugs squeeze budgets, according to a new survey released by ...
ET HealthWorld4d
Many US employers plan to pare health benefits as weight-loss spending soars
While some employers have covered GLP-1s hoping for long-term health savings, rising prices are forcing a rethink: "Some ...
Tribune Chronicle5d
Prices down for Wegovy and Zepbound
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging. The ...
Rocky Mount Telegram6d
Wegovy and Zepbound prices fall, but access to the obesity drugs still isn’t guaranteed
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging.